Aims and objectives

• to improve rapid diagnosis and treatment of infectious diseases with focus on both common and rare infections
• to reduce use of broad spectrum antibiotics
• to improve diagnosis, treatment and prevention of infectious diseases in patients with co-morbidity and secondary immunosuppression
• to participate in national and international research projects with focus on pneumonia, tuberculosis, HIV, viral hepatitis, CNS infections and infections in the immunocompromised host

Focus areas:

• Infectious diseases caused by bacteria, virus, parasites and fungi.
• Diagnostic and therapeutic challenges.
  • Pneumonia: OptiCAP (OPtimising Treatment of Community Acquired Pneumonia, A quality assessment, multicenter collaboration)
    • Aims are to reduce:

Door to needle time, total length of iv and oral antibiotics, proper microbiological assessment and re-evaluation <72 hours

• Improving microbiological sampling in patients with pneumonia, a RCT. (KUPL)
• Validation of CAVE penicillin to increase the use of penicillin and to decrease the use of broad spectrum antibiotics, a multicenter study; Antibiotic Stewardship.
• Central Nervous Infections, DASGIB (Danish Study Group for Infections in the Brain) a multicenter collaboration, research and quality assessment.
• Chronic viral infections, multicenter collaboration, research and quality assessment participation in: The Danish HIV cohort (DHK) and the Danish hepatitis cohort (DAN-HEP), The Danish Post Exposure Prophylaxis (PEP) registry
• Co-morbidities and infections
  • Pneumonia and Diabetes. Assessment of prevalence and interactions in patients with double burden of disease. Cap North a Danish pneumonia cohort in collaboration with  www.CAPNETZ.de
  • TB and Diabetes. Assessment of prevalence and interactions in patients with double burden of disease. (The Danish Diabetes study (multicenter collaboration P.I at SDCC and HGH)
  • TB and hepatitis, a Danish prevalence study
  • Tuberculosis
    • TB in asylum seekers, a register and a clinical study.
• Prevention of diseases in immunosuppressed individuals.

• Assessment of diagnostic tests for latent TB infection among immunosuppressed individuals and patients with diabetes Multicenter study www.TBNET.eu

Disciplines, methods, tools:

• Clinical science
• Epidemiological studies